Crossmark

Association of sarcopenia and longitudinal changes in sarcopenia status with all-cause mortality in individuals with cardiovascular-kidney-metabolic syndrome

Crossref DOI link: https://doi.org/10.1186/s12986-026-01197-y

Published Online: 2026-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xinzhong

Tian, Yong

Ren, Xiaoying

Wang, Guang https://orcid.org/0000-0001-9321-5200
Liu, Jia https://orcid.org/0000-0002-6957-3814
Funding

Funding for this research was provided by:

the National Key R&D Program of China (No. 2022YFA0806400)

National Natural Science Foundation of China (No. 82470889)

Beijing Natural Science Foundation (No. L248018)
License Information

Text and Data Mining valid from 2026-09-05

Accepted Manuscript valid from 2026-09-05
More Information

Article History

Received: 17 October 2025

Accepted: 27 August 2026

First Online: 5 September 2026

Declarations

Ethics approval and consent to participate: The CHARLS study received ethical approval from the Biomedical Ethics Review Committee of Peking University (IRB00001052-11015), and written informed consent was obtained from all participants. This study used publicly available de-identified CHARLS data and therefore did not require additional ethical approval.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below